Herceptin (trastuzamab) in advanced breast cancer

This publication has 21 references indexed in Scilit:

• Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy
  Journal of Clinical Oncology, 1999
• Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer
  JNCI Journal of the National Cancer Institute, 1998
• Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women.
  Journal of Clinical Oncology, 1998
• Polychemotherapy for early breast cancer: an overview of the randomised trials
  The Lancet, 1998
• Recent Trends in U.S. Breast Cancer Incidence, Survival, and Mortality Rates
  JNCI Journal of the National Cancer Institute, 1996
• Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer.
  Journal of Clinical Oncology, 1995
• Treatment of relapse of breast cancer after adjuvant systemic therapy — Review and guidelines for future research
  European Journal Of Cancer, 1994
• Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.
  Journal of Clinical Oncology, 1992
• Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
  Science, 1987
• p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity.
  Molecular and Cellular Biology, 1986